Where time machines meet viral vector vaccines

New KUBio BSL-2: The solution for rapid deployment of viral vector expansion

Making vein to vein easier and easier

GE expands cell therapy portfolio with first system for both isolation and harvesting

Learn More

75% of recent winners of the Nobel Prize relied on a DeltaVision microscope in their research

Read Story

Resource center

New resource center with fundamentals and tips, for beginners to experts

Article

How to win in emerging biopharma markets

News

Collaboration on new technology for viral vector production

Blog

Gene and Eva explore tech transfer, and it's not always smooth sailing